NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir
Nucleoside analogs (NNA), such as acyclovir (ACV) and ganciclovir (GCV), are widely used as anti-virals to treat herpes virus infection. Here, Nishii et al. show that diphosphatase NUDT15 hydrolyzes ACV and GCV, therewith reducing NNA activity in vitro and link NUDT15 variation to inter-patient vari...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-24509-7 |
id |
doaj-ac367d8e92bf4e2bb684ff635f13452f |
---|---|
record_format |
Article |
spelling |
doaj-ac367d8e92bf4e2bb684ff635f13452f2021-07-11T11:42:19ZengNature Publishing GroupNature Communications2041-17232021-07-011211910.1038/s41467-021-24509-7NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovirRina Nishii0Takanori Mizuno1Daniel Rehling2Colton Smith3Brandi L. Clark4Xujie Zhao5Scott A. Brown6Brandon Smart7Takaya Moriyama8Yuji Yamada9Tatsuo Ichinohe10Makoto Onizuka11Yoshiko Atsuta12Lei Yang13Wenjian Yang14Paul G. Thomas15Pål Stenmark16Motohiro Kato17Jun J. Yang18Department of Pharmaceutical Sciences, St. Jude Children’s Research HospitalChildren’s Cancer Center, National Center for Child Health and DevelopmentDepartment of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm UniversityDepartment of Pharmaceutical Sciences, St. Jude Children’s Research HospitalDepartment of Immunology, St. Jude Children’s Research HospitalDepartment of Pharmaceutical Sciences, St. Jude Children’s Research HospitalDepartment of Immunology, St. Jude Children’s Research HospitalDepartment of Pharmaceutical Sciences, St. Jude Children’s Research HospitalDepartment of Pharmaceutical Sciences, St. Jude Children’s Research HospitalChildren’s Cancer Center, National Center for Child Health and DevelopmentResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityTokai University School of MedicineJapanese Data Center for Hematopoietic Cell TransplantationDepartment of Chemical Biology & Therapeutics, St. Jude Children’s Research HospitalDepartment of Pharmaceutical Sciences, St. Jude Children’s Research HospitalDepartment of Immunology, St. Jude Children’s Research HospitalDepartment of Biochemistry and Biophysics, Arrhenius Laboratories for Natural Sciences, Stockholm UniversityChildren’s Cancer Center, National Center for Child Health and DevelopmentDepartment of Pharmaceutical Sciences, St. Jude Children’s Research HospitalNucleoside analogs (NNA), such as acyclovir (ACV) and ganciclovir (GCV), are widely used as anti-virals to treat herpes virus infection. Here, Nishii et al. show that diphosphatase NUDT15 hydrolyzes ACV and GCV, therewith reducing NNA activity in vitro and link NUDT15 variation to inter-patient variability in ACV and GCV therapeutic effects.https://doi.org/10.1038/s41467-021-24509-7 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rina Nishii Takanori Mizuno Daniel Rehling Colton Smith Brandi L. Clark Xujie Zhao Scott A. Brown Brandon Smart Takaya Moriyama Yuji Yamada Tatsuo Ichinohe Makoto Onizuka Yoshiko Atsuta Lei Yang Wenjian Yang Paul G. Thomas Pål Stenmark Motohiro Kato Jun J. Yang |
spellingShingle |
Rina Nishii Takanori Mizuno Daniel Rehling Colton Smith Brandi L. Clark Xujie Zhao Scott A. Brown Brandon Smart Takaya Moriyama Yuji Yamada Tatsuo Ichinohe Makoto Onizuka Yoshiko Atsuta Lei Yang Wenjian Yang Paul G. Thomas Pål Stenmark Motohiro Kato Jun J. Yang NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir Nature Communications |
author_facet |
Rina Nishii Takanori Mizuno Daniel Rehling Colton Smith Brandi L. Clark Xujie Zhao Scott A. Brown Brandon Smart Takaya Moriyama Yuji Yamada Tatsuo Ichinohe Makoto Onizuka Yoshiko Atsuta Lei Yang Wenjian Yang Paul G. Thomas Pål Stenmark Motohiro Kato Jun J. Yang |
author_sort |
Rina Nishii |
title |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_short |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_full |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_fullStr |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_full_unstemmed |
NUDT15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
title_sort |
nudt15 polymorphism influences the metabolism and therapeutic effects of acyclovir and ganciclovir |
publisher |
Nature Publishing Group |
series |
Nature Communications |
issn |
2041-1723 |
publishDate |
2021-07-01 |
description |
Nucleoside analogs (NNA), such as acyclovir (ACV) and ganciclovir (GCV), are widely used as anti-virals to treat herpes virus infection. Here, Nishii et al. show that diphosphatase NUDT15 hydrolyzes ACV and GCV, therewith reducing NNA activity in vitro and link NUDT15 variation to inter-patient variability in ACV and GCV therapeutic effects. |
url |
https://doi.org/10.1038/s41467-021-24509-7 |
work_keys_str_mv |
AT rinanishii nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT takanorimizuno nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT danielrehling nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT coltonsmith nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT brandilclark nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT xujiezhao nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT scottabrown nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT brandonsmart nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT takayamoriyama nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT yujiyamada nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT tatsuoichinohe nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT makotoonizuka nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT yoshikoatsuta nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT leiyang nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT wenjianyang nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT paulgthomas nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT palstenmark nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT motohirokato nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir AT junjyang nudt15polymorphisminfluencesthemetabolismandtherapeuticeffectsofacyclovirandganciclovir |
_version_ |
1721308821925658624 |